Literature DB >> 1456571

Bronchial exudation of bulk plasma at allergen challenge in allergic asthma.

P Salomonsson1, R Grönneberg, H Gilljam, O Andersson, B Billing, I Enander, U Alkner, C G Persson.   

Abstract

This study examined plasma exudation into the bronchial lumen after allergen challenge. A novel low-trauma technique was developed to challenge and lavage a medium-sized lingular or middle lobe bronchus. Eleven subjects with challenge-assessed pollen-sensitive asthma were allocated to fiberbronchoscopy in the supine position. In the control bronchus 0.5 ml diluent was instilled. The bronchus was occluded proximally 3 min later by inflation of a balloon, and lavage was carried out twice with 25 ml saline. Incremental doses of allergen solution (0.5 ml) were then instilled in the contralateral lung. The challenge continued until a clearly visible bronchial reaction occurred and was immediately followed by the same lavage as on the control side. The lavage liquids were analyzed for the presence of plasma exudation and mast cell activation indices. On the allergen-challenged side, tryptase, reflecting mast cell activation, was increased by 150% (p < 0.01) compared with the control side. Fibrinogen (mol wt 340,000), reflecting large protein exudation, was increased by 840% (p < 0.05), and N-alpha-tosyl-L-arginine-methyl esterase activity, reflecting both large protein exudation and mast cell activation, increased by 480% (p < 0.01). The level of albumin (mol wt 69,000), the major luminal protein under baseline conditions, increased but not significantly. We conclude that activation of mast cells and luminal entry of little sieved plasma exudates occur early after endobronchial allergen provocation in human subjects with allergic asthma.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1456571     DOI: 10.1164/ajrccm/146.6.1535

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  11 in total

1.  Binding of Aspergillus fumigatus spores to lung epithelial cells and basement membrane proteins: relevance to the asthmatic lung.

Authors:  I M Bromley; K Donaldson
Journal:  Thorax       Date:  1996-12       Impact factor: 9.139

2.  Effects of inhaled histamine, methacholine and capsaicin on sputum levels of alpha 2-macroglobulin.

Authors:  H Halldorsdottir; L Greiff; P Wollmer; M Andersson; C Svensson; U Alkner; C G Persson
Journal:  Thorax       Date:  1997-11       Impact factor: 9.139

Review 3.  Humoral First-Line Mucosal Innate Defence in vivo.

Authors:  Carl Persson
Journal:  J Innate Immun       Date:  2020-03-23       Impact factor: 7.349

4.  Effects of nicotine on the human nasal mucosa.

Authors:  L Greiff; P Wollmer; I Erjefält; M Andersson; U Pipkorn; C G Persson
Journal:  Thorax       Date:  1993-06       Impact factor: 9.139

5.  Microvascular exudative hyperresponsiveness in human coronavirus-induced common cold.

Authors:  L Greiff; M Andersson; A Akerlund; P Wollmer; C Svensson; U Alkner; C G Persson
Journal:  Thorax       Date:  1994-02       Impact factor: 9.139

6.  Effects of topical capsaicin in seasonal allergic rhinitis.

Authors:  L Greiff; C Svensson; M Andersson; C G Persson
Journal:  Thorax       Date:  1995-03       Impact factor: 9.139

7.  Histamine-induced airway mucosal exudation of bulk plasma and plasma-derived mediators is not inhibited by intravenous bronchodilators.

Authors:  C Svensson; U Alkner; U Pipkorn; C G Persson
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

Review 8.  Airways exudation of plasma macromolecules: Innate defense, epithelial regeneration, and asthma.

Authors:  Carl Persson
Journal:  J Allergy Clin Immunol       Date:  2018-08-29       Impact factor: 10.793

9.  Exudative hyperresponsiveness of the airway microcirculation in seasonal allergic rhinitis.

Authors:  C Svensson; M Andersson; L Greiff; U Alkner; C G Persson
Journal:  Clin Exp Allergy       Date:  1995-10       Impact factor: 5.018

Review 10.  Mechanisms of nasal hyper-reactivity.

Authors:  M Andersson; L Greiff; C Svensson; C Persson
Journal:  Eur Arch Otorhinolaryngol       Date:  1995       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.